Evidence map›Paper›PMID 22493279›Full record

ArticleJournal of medical microbiology2012

Globally dispersed mobile drug-resistance genes in gram-negative bacterial isolates from patients with bloodstream infections in a US urban general hospital.

S Adams-Sapper, J Sergeevna-Selezneva, S Tartof, E Raphael, B An Diep, F Perdreau-Remington, L W Riley

Open access · greenAbstract read
In one paragraph

Article in Journal of medical microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. ExploringPharmaceuticals (Basel, Switzerland) · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

S Adams-SapperSchool of Public Health, Division of Infectious Diseases and Vaccinology, University of California, Berkeley, CA, USA.
J Sergeevna-SeleznevaSchool of Public Health, Division of Infectious Diseases and Vaccinology, University of California, Berkeley, CA, USA.
S TartofSchool of Public Health, Division of Infectious Diseases and Vaccinology, University of California, Berkeley, CA, USA.
E RaphaelSchool of Public Health, Division of Infectious Diseases and Vaccinology, University of California, Berkeley, CA, USA.
B An DiepDepartment of Medicine, University of California, San Francisco, CA, USA.
F Perdreau-RemingtonDepartment of Medicine, University of California, San Francisco, CA, USA.
L W RileySchool of Public Health, Division of Infectious Diseases and Vaccinology, University of California, Berkeley, CA, USA.
University of California, Berkeley · USUniversity of California, San Francisco · US

Funding

Orgin of multidrug resistant uropathogenic E. coliR01AI059523 · NIAID · UNIVERSITY OF CALIFORNIA BERKELEY · PI RILEY, LEE W · 2005 to 2008
$1.2M
NIAID NIH HHS AI059523NIAID NIH HHS R01 AI059523
6 · The paper itself

Abstract

Mobile drug-resistance genes with identical nucleic acid sequences carried by multidrug-resistant Escherichia coli strains that cause community-acquired infections are becomingly increasingly dispersed worldwide. Over a 2-year period, we analysed gram-negative bacterial (GNB) pathogens from the blood of inpatients at an urban public hospital to determine what proportion of these isolates carried such globally dispersed drug-resistance genes. Of 376 GNB isolates, 167 (44 %) were Escherichia coli, 50 (13 %) were Klebsiella pneumoniae, 25 (7 %) were Pseudomonas aeruginosa, 25 (7 %) were Proteus mirabilis and 20 (5 %) were Enterobacter cloacae; the remainder (24 %) comprised 26 different GNB species. Among E. coli isolates, class 1 integrons were detected in 64 (38 %). The most common integron gene cassette configuration was dfrA17-aadA5, found in 30 (25 %) of 119 drug-resistant E. coli isolates and in one isolate of Moraxella morganii. Extended-spectrum β-lactamase (ESBL) genes were found in 16 E. coli isolates (10 %). These genes with identical sequences were found in nearly 40 % of bloodstream E. coli isolates in the study hospital, as well as in a variety of bacterial species from clinical and non-clinical sources worldwide. Thus, a substantial proportion of bloodstream infections among hospitalized patients were caused by E. coli strains carrying drug-resistance genes that are dispersed globally in a wide variety of bacterial species.

Indexed as

Drug Resistance, BacterialInterspersed Repetitive SequencesAnti-Bacterial AgentsBacteremiaDNA, BacterialGenes, BacterialGram-Negative BacteriaGram-Negative Bacterial InfectionsHospitals, GeneralHumansPrevalenceSequence Analysis, DNAUnited StatesUrban PopulationAnti-Bacterial AgentsDNA, Bacterial

Identifiers

PMID22493279
PMCPMC3542709
OpenAlexW2061956959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.